US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
ETF
アメリカ
AMEX
State Street SPDR S&P 600 Small Cap Growth ETF (SLYG)
State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) オプション

State Street SPDR S&P 600 Small Cap Growth ETF (SLYG)

114.17

2.11

(1.88%)

終了 6月21日 5:00AM

114.21

0.04

(0.04%)

取引時間後: 8:59AM

State Street SPDR S&P 600 Small Cap Growth ETF ([symbol]) オプションチェーン

SLYG ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
104.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
105.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
106.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
107.00	0.00	0.00	7.40	7.40	0.00	0.00 %	0	0	-
108.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
109.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
110.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
111.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
112.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
113.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
114.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
115.00	0.00	0.00	2.55	2.55	0.00	0.00 %	0	9	-
116.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
117.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
118.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
119.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
104.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
105.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
106.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
107.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
108.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
109.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
110.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
111.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
112.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
113.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
114.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
115.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
116.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
117.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
118.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
119.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ADTXAditxt Inc	US$ 0.01 (127.27%)	5.38B
LNKSLinkers Industries Ltd	US$ 2.6509 (65.68%)	69.88M
CASTFreeCast Inc	US$ 8.0101 (55.54%)	113.02M
CDTCDT Equity Inc	US$ 1.0101 (45.76%)	249.47M
APWCAsia Pacific Wire and Cable Corporation Ltd	US$ 2.02 (45.32%)	48.09M
INLFINLIF Limited	US$ 0.1533 (-64.95%)	131.52M
SNBRSleep Number Corporation	US$ 0.2152 (-44.82%)	52.75M
YYGHYY Group Holding Ltd	US$ 0.0791 (-38.63%)	82.04M
LABTLakewood-Amedex Biotherapeutics Inc	US$ 0.3852 (-36.03%)	1.83M
EHGOEshallgo Inc	US$ 1.895 (-34.43%)	2.2M
ADTXAditxt Inc	US$ 0.01 (127.27%)	5.38B
GDCGD Culture Group Ltd	US$ 0.0177 (-16.90%)	931.09M
SPCXSpace Exploration Technologies Corporation	US$ 185.00 (-3.56%)	272.29M
MRVLMarvell Technology Inc	US$ 310.58 (7.27%)	251.45M
CDTCDT Equity Inc	US$ 1.0101 (45.76%)	249.47M

MONTI KING

MONTI KING 5分前

Nothing wrong with putting out hypothetical situations

MONTI KING

MONTI KING 7分前

Go to LinkedIn.. search VitOrgan.. you will find a lot of profiles working for them, many mention Biomolecular in their profiles. You have to get translations from German to English .. which is what I did.

flipper44

flipper44 8分前

T cell therapy still only impressive in B cell blood cancers. Why, because T cell therapy is used to target self in the body that our immune systems avoid attacking. B cells are not necessary to survive if completely removed from our systems temporarily.

Genetically modified dendrit

Lord Andreti

Lord Andreti 8分前

I’d take that 100,000% run all day every day lol.

Can’t get in to this right now, if I don’t have something concrete to stare at.

jammy32

jammy32 14分前

Isn’t this from 2018 ? Maybe this explains the problem with the PPS

Look I agree with all that we should be worth more. That said , we’re not. That’s why we hold CEO’s accountable for stock performance. For creating shareholder value. Nasrat has overseen a 50 percent drop

Monksdream

Monksdream 17分前

AMZN, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/jbwszIMG_2249.png

learningcurve2020

learningcurve2020 18分前

https://people.com/dad-thought-dizziness-was-from-quitting-drinking-alcohol-turned-out-to-be-brain-tumor-12001899

🤷‍♀️

jammy32

jammy32 23分前

Elite is doing well with the exception of the PPS. That’s all I care about. Nothing else. 82 cents to 36 cents is unacceptable. Especially for such a so called great company. So , great results but crappy PPS. That’s on Nasrat as he doesn’t manage the PPS. He doesn’t seem to care.

learningcurve2020

learningcurve2020 24分前

Any updates from Danish’s House? Is that band playing? All you can eat pancakes?

R1250gs

R1250gs 24分前

My target is to own 1000 Sol's and put them into a self-custody crypto wallet for a long term investment. I think Sol has a tremendous potential to grow big...

Mister4

Mister4 31分前

Yes, the NWS was certainly illegal. That being said, in my opinion, the terms of the conservatorship are a major Takings violation. Who gives a loan that when paid off the lender owns 95% of the collateral for the loan? The warrants alone represent 80% of the outstanding stock. Who besides the gover

CanItBThisEZ2Make

CanItBThisEZ2Make 33分前

BEST SELLERS RANK (BSR) IS 356 45 Estimated Sold on Amazon Since APRIL 1 - 2ND Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D

SeaBlue

SeaBlue 40分前

Rules for thee and not for me - that is what is going on with the Trumper family AND CONgress.

I'll watch the Tom Lee video in a while - gotta head out on some errands.

I am looking forward to what is hopefully good news from the federal/provincial govt. by the end of

CaptBeer

CaptBeer 40分前

REDUCE-IT CKM: In REDUCE-IT secondary prevention patients, the CKM syndrome was associated with incremental CVD risk compared with MetS without diabetes and normal renal function. IPE treatment further reduced CVD risk in patients with CKM, thereby supporting a role for this therapy in affected pati

toohot

toohot 42分前

Conductor TOOHOT checking in—thanks for your patience during the brief pause.
The BIEL Train Bound for Glory resumes boarding this Monday.
Entry prices remain low—for now.
All aboard to those joining the ride. 🚂
$BIEL

BUY $BI

Implanting

Implanting 42分前

Here's the interview. Frank G. is one of my favorites.

https://www.youtube.com/watch?v=bNuljOP4Ric

Investor2014

Investor2014 42分前

Don't forget the 58 amazing scientists signing away their reputation on the peer reviewed paper and the entire Scientific Advisory Board that must have been implicit too.

The alternative is simply a poorly run biotech with a drug that may not work well enough to gain approval and a bu

DJknows

DJknows 47分前

Of course I agree with you ... there's no way IQM Quantum is not familiar with Perkinamine and who knows to what extent they're using it.

Dr. Ciesla is joing an apparently impressive team at IQM, which has four co-founders according to its website:

https://iqm.tech/pres

learningcurve2020

learningcurve2020 49分前

“Safe” yet no pediatric trials for the most vulnerable? Safe is good but can also be a red flag that the drug/cell therapy is not active enough. My guess is skip right over DCVAX to genetically modified DC’s. 🤷‍♀️. Hopefully the CDMO is preparing??

Sunnybank

Sunnybank 50分前

Mates-Have a wonderful Father's Day with parents and/or children. Fair Winds to All!

Monksdream

Monksdream 50分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

Monksdream

Monksdream 50分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

SeaBlue

SeaBlue 52分前

Video with Frank G. Just watch from about 37:20 to 39:10. This is good news, particularly for Duparquet, but also for Springpole. Improved permitting times will help FF a lot. I am also glad because the money generated will be good for Canada.
https://www.youtube.com/watch?v=bNuljOP4Ri

learningcurve2020

learningcurve2020 53分前

T cell and Genetically modified dendritic cells.

Lacey1

Lacey1 54分前

What did it cost to produce that report? And how long to write it up. Looks like a pure hit piece. Effective in driving the price to all time lows. Where do we go from here. We need a partner. We need to submit to the FDA for NDA this year. Is that still a possibility? With Kennedy at the

State Street SPDR S&P 60...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。